from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1979c/-

LFCtreatmentdescriptionclass of inhibitor

0.460

Amikacinug/mL Amikacintranslation

0.839

Cap5-10ug/mL Capreomycintranslation

0.585

Rox10-50 ug/mL Roxithromycintranslation

0.261

SM2-5 ug/mL Streptomycintranslation

-0.331

Tet5-10 ug/mL Tetracyclinetranslation

0.385

Rif0.2-5ug/mL Rifampicintranscription

0.672

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.244

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.447

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.564

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.852

Clofazimine10-13 ug/mL Clofaziminerespiration

0.893

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.964

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.441

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.887

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.978

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.083

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.616

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-2.214

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.987

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-2.379

KCN5-20 ug/mL Potassium cyaniderespiration

-0.659

NaN30.2-2 mM Sodium aziderespiration

0.025

Nigericin50 uM Nigericinrespiration

-0.098

TRC10-150 ug/mL Triclosanrespiration

-0.698

TRZ10-25 ug/mL Thioridazinerespiration

0.825

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.494

menadione6-10 ug/mL Menadionerespiration

-0.314

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.175

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.072

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.689

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.262

NRP_1Non-replicating persistence stage 1dosRassociated

-0.301

Amp0.2mg/mL AmpicillincellWall

0.313

Cephalexin20-100 ug/mL CephalexincellWall

1.786

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.012

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.007

EMB10-20 ug/mL EthambutolcellWall

-0.018

Eta12-40 ug/mL EthionamidecellWall

0.092

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.070

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.361

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.451

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.024

BZA0.12 mg/mL BenzamidearomaticAmides

0.207

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.088

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

1.079

H2O24 mM hydrogen peroxideDNAdamaging

0.107

Levo10 ug/mL LevofloxacinDNAdamaging

0.242

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.032

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.101

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.067

UVUV-irradiationDNAdamaging

-0.019

ARP41-4 ug/mL Antitubercular compound ARP4?

0.718

Antimycin12.5-50 ug/mL Antimycin A?

-0.375

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.947

PA_110-50 ug/mL Antitubercular compound PA-1?

0.041

PA_2110-50 ug/mL Antitubercular compound PA-21?

-2.020

PA8240.2-2 ug/mL PA-824?

-1.051

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.370

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.222

Verapamil50 uM Verapamil?

-0.574

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.176

methoxatin10-20 ug/mL Methoxatin?